Inhibiting the phosphatase activity of soluble epoxide hydrolase reduces arterial calcification and prevents the cardiovascular complications of chronic kidney disease

被引：0
|
作者：
Messaoudi, H. [1 ]
Varennes, O. [2 ]
Perzo, N. [1 ]
Berg, E. [1 ]
Levesque, T. [1 ,3 ]
Duflot, T. [1 ,4 ]
Chegrani, G. [1 ]
Kauffenstein, G. [5 ]
Dumesnil, A. [1 ]
Mulder, P. [1 ]
Brunel, V. [6 ]
Six, I. [2 ]
Mentaverri, R. [2 ]
Guerrot, D. [1 ,4 ]
Hamzaoui, M. [1 ,4 ]
Richard, V. [1 ,4 ]
Morisseau, C. [7 ,8 ]
Kamel, S. [2 ]
Proschak, E. [9 ]
Bellien, J. [1 ,4 ]
机构：
[1] Normandy Univ, UniRouen, FHU CARNAVAL, INSERM,UMR 1096,EnVI, F-76000 Rouen, France
[2] Univ Picardie Jules Verne, Ctr Rech Univ Sante, EA 7517, Mecanismes Physiopathol & Consequences Calcificat, Amiens, France
[3] Rouen Univ Hosp, Dept Cardiol, F-76000 Rouen, France
[4] Rouen Univ Hosp, Dept Pharmacol, F-76000 Rouen, France
[5] Strasbourg Univ, INSERM, UMR 1260, CRBS, Strasbourg, France
[6] Rouen Univ Hosp, Dept Gen Biochem, F-76000 Rouen, France
[7] Univ Calif Davis, Dept Entomol & Nematol, Davis, CA 95616 USA
[8] Univ Calif Davis, UCD comprehens Canc Ctr, Davis, CA 95616 USA
[9] Goethe Univ, Inst Pharmaceut Chem, Max von Laue Str 9, D-60438 Frankfurt, Germany
来源：
FUNDAMENTAL & CLINICAL PHARMACOLOGY | 2022年 / 36卷
关键词：
vascular calcification; phosphatase's soluble epoxide hydrolase; pyrophosphate; PPARg; chronic kidney disease;
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
CO-028
引用
收藏
页码：24 / 25
页数：2
相关论文
共 25 条
  • [1] IMPACT OF THE INHIBITION OF SOLUBLE EPOXIDE HYDROLASE ON CARDIOVASCULAR CONSEQUENCES OF CHRONIC KIDNEY DISEASE
    Hamzaoui, M.
    Roche, C.
    Lejeune, A.
    Brunel, V.
    Richard, V.
    Bellien, J.
    Guerrot, D.
    JOURNAL OF HYPERTENSION, 2016, 34 : E51 - E51
  • [2] Impact of the inhibition of soluble epoxide hydrolase on cardiovascular consequences of chronic kidney disease
    Hamzaoui, M.
    Roche, C.
    Lejeune, A.
    Brunel, V.
    Richard, V.
    Bellien, J.
    Guerrot, D.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2016, 30 : 33 - 33
  • [3] Deletion of soluble epoxide hydrolase suppressed chronic kidney disease-related vascular calcification by restoring Sirtuin 3 expression
    Wanbing He
    Jieping Huang
    Yang Liu
    Changming Xie
    Kun Zhang
    Xinhong Zhu
    Jie Chen
    Hui Huang
    Cell Death & Disease, 12
  • [4] Deletion of soluble epoxide hydrolase suppressed chronic kidney disease-related vascular calcification by restoring Sirtuin 3 expression
    He, Wanbing
    Huang, Jieping
    Liu, Yang
    Xie, Changming
    Zhang, Kun
    Zhu, Xinhong
    Chen, Jie
    Huang, Hui
    CELL DEATH & DISEASE, 2021, 12 (11)
  • [5] Genetically Reduced Soluble Epoxide Hydrolase Activity and Risk of Stroke and Other Cardiovascular Disease
    Lee, Julie
    Dahl, Morten
    Grande, Peer
    Tybjaerg-Hansen, Anne
    Nordestgaard, Borge G.
    STROKE, 2010, 41 (01) : 27 - 33
  • [6] The metabolic signature of cardiovascular disease and arterial calcification in patients with chronic kidney disease
    Sorensen, Ida MH.
    Bisgaard, Line S.
    Bjergfelt, Sasha S.
    Ballegaard, Ellen LF.
    Biering-Sorensen, Tor
    Landler, Nino E.
    Pedersen, Tanja X.
    Kofoed, Klaus F.
    Lange, Theis
    Feldt-Rasmussen, Bo
    Bro, Susanne
    Christoffersen, Christina
    ATHEROSCLEROSIS, 2022, 350 : 109 - 118
  • [7] Are there ways to attenuate arterial calcification and improve cardiovascular outcomes in chronic kidney disease?
    Vo, Thanh-Mai
    Disthabanchong, Sinee
    WORLD JOURNAL OF CARDIOLOGY, 2014, 6 (05): : 216 - 226
  • [8] CRISPR/Cas9-mediated inactivation of the phosphatase activity of soluble epoxide hydrolase prevents obesity and cardiac ischemic injury
    Leuillier, Matthieu
    Duflot, Thomas
    Menoret, Severine
    Messaoudi, Hind
    Djerada, Zoubir
    Groussard, Deborah
    Denis, Raphael G. P.
    Chevalier, Laurence
    Karoui, Ahmed
    Panthu, Baptiste
    Thiebaut, Pierre-Alain
    Schmitz-Afonso, Isabelle
    Nobis, Severine
    Campart, Cynthia
    Henry, Tiphaine
    Sautreuil, Camille
    Luquet, Serge H.
    Beseme, Olivia
    Feliu, Catherine
    Peyret, Helene
    Nicol, Lionel
    Henry, Jean-Paul
    Renet, Sylvanie
    Mulder, Paul
    Wan, Debin
    Tesson, Laurent
    Heslan, Jean-Marie
    Duche, Angeline
    Jacques, Sebastien
    Ziegler, Frederic
    Brunel, Valery
    Rautureau, Gilles J. P.
    Monteil, Christelle
    do Rego, Jean-Luc
    do Rego, Jean-Claude
    Afonso, Carlos
    Hammock, Bruce
    Madec, Anne-Marie
    Pinet, Florence
    Richard, Vincent
    Anegon, Ignacio
    Guignabert, Christophe
    Morisseau, Christophe
    Bellien, Jeremy
    JOURNAL OF ADVANCED RESEARCH, 2023, 43 : 163 - 174
  • [9] METABOLIC PROFILING AS A MARKER OF CARDIOVASCULAR DISEASE AND ARTERIAL CALCIFICATION IN THE COPENHAGEN CHRONIC KIDNEY DISEASE COHORT
    Soerensen, Ida Maria Hjelm
    Bisgaard, Line Stattau
    Bjergfelt, Sasha Saurbrey
    Ballegaard, Ellen Linnea Freese
    Biering-Sorensen, Tor
    Landler, Nino Emanuel
    Kofoed, Klaus F.
    Lange, Theis
    Feldt-Rasmussen, Bo
    Bro, Susanne
    Christoffersen, Christina
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2021, 36
  • [10] Cardiovascular risk markers associated with arterial calcification in patients with chronic kidney disease Stages 3 and 4
    Weber, Chek Ing Kiu
    Duchateau-Nguyen, Guillemette
    Solier, Corinne
    Schell-Steven, Annette
    Hermosilla, Ricardo
    Nogoceke, Everson
    Block, Geoffrey
    CLINICAL KIDNEY JOURNAL, 2014, 7 (02): : 167 - 173
123